NCT02116764View on ClinicalTrials.gov

Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

June 11, 2014

Primary Completion Date

June 2, 2022

Study Completion Date

June 2, 2022

Conditions
Chronic Granulomatous Disease
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02116764 - Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995 | Biotech Hunter | Biotech Hunter